Discover the 2023 Cell Therapy Landscape Review

A comprehensive analysis of the drug, trial, and commercial landscape, including updates from 2023, relevant regulatory announcements, and the future of the cell therapy landscape.

Download Here

About the 2023 Landscape Review

The Cell Therapy field is evolving fast. CAR T cells and CD19 are the most commonly developed therapeutic classes. Armored cell therapies with KI, KO, and KD genes are gaining interest. In 2023, cell therapy expanded, particularly in autoimmune diseases. Exagamglogene autotemcel, the first CRISPR-edited cell therapy received landmark approval.

Developers are moving away from developing T Cells and into NK cells. Over 60% of NK therapies are allogeneic versus only 21% of T cell therapies. It’s important to follow trends in patient enrolment for early phase trials for non-oncology indications, with a 10% growth rate in non-oncology deals compared to a 10% decrease in cancer indications. Get all this information and more in our 2023 Cell Therapy Landscape report. Download now.

You may also be interested in...

Exploring Allogeneic Cell Therapies: Pioneering Advantages and Recent Innovations

Find out more

Unlock the Future of Advanced Therapies: Insights from the ASGCT 2024 Annual Meeting

Find out more

Beacon Cell Therapy: 2024 ASGCT Annual Meeting Abstracts

Find out more

2023 Gene Therapy Landscape Review

Find out more

The 2023 RNA Landscape Review

Find out more

2023 Cell Therapy Landscape Review

Find out more

Find out more

Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.

Each dataset features proprietary, hyper-relevant search and filtering tailored to specific modalities, in-depth data, plus additional market insight curated by our subject matter experts. Beacon is here to support you in making these decisions with confidence through our encompassing database solution.

With Beacon, you can make drug development decisions with confidence. This is why 23 out of the world’s top 25 drug developers trust us.


Discover more about Beacon

Any questions? Get in touch

Our dedicated account and research teams can help you with questions by showing you how this insight and data is collated on Beacon.





 Get Started